Rathbones Group PLC Sells 12,212 Shares of Danaher Corporation $DHR

Rathbones Group PLC lowered its position in Danaher Corporation (NYSE:DHR) by 4.6% during the 1st quarter, HoldingsChannel reports. The fund owned 253,287 shares of the conglomerate’s stock after selling 12,212 shares during the period. Rathbones Group PLC’s holdings in Danaher were worth $48,023,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in DHR. Elevated Capital Advisors LLC bought a new position in Danaher during the 4th quarter valued at about $26,000. Hilton Head Capital Partners LLC bought a new stake in Danaher in the fourth quarter worth about $27,000. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the period. JPL Wealth Management LLC purchased a new position in shares of Danaher during the third quarter valued at approximately $25,000. Finally, Main Street Group LTD bought a new position in shares of Danaher during the first quarter valued at approximately $25,000. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research analyst reports. Morgan Stanley decreased their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Guggenheim reduced their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Finally, Barclays lowered their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Stock Up 0.1%

Shares of NYSE DHR opened at $195.25 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a market capitalization of $137.26 billion, a price-to-earnings ratio of 34.68, a PEG ratio of 2.43 and a beta of 0.78. The stock has a 50 day moving average price of $188.36 and a 200 day moving average price of $195.35. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the business posted $0.77 EPS. Sell-side analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, July 31st. Stockholders of record on Friday, June 26th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s dividend payout ratio is presently 28.42%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.